An Open-label, Single-dose, Randomized-to-sequence, 4-period Crossover Bioavailability Study of Bazedoxifene Contained in Bazedoxifene/Conjugated Estrogen Tablets Administered to Healthy Postmenopausal Women

Trial Profile

An Open-label, Single-dose, Randomized-to-sequence, 4-period Crossover Bioavailability Study of Bazedoxifene Contained in Bazedoxifene/Conjugated Estrogen Tablets Administered to Healthy Postmenopausal Women

Completed
Phase of Trial: Phase I

Latest Information Update: 07 May 2015

At a glance

  • Drugs Conjugated estrogens/bazedoxifene (Primary) ; Bazedoxifene
  • Indications Atrophic vaginitis; Postmenopausal osteoporosis; Vasomotor symptoms
  • Focus Pharmacokinetics
  • Sponsors Wyeth
  • Most Recent Events

    • 07 Dec 2006 The expected completion date for this trial is now 31 Aug 2006.
    • 18 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top